Evidence map›Paper›PMID 41131063›Full record

ArticleScientific reports2025

Synergistic bactericidal and anticancer potential of rubidium and silver-containing phosphate-based bioglasses.

M Bosca, L C Bolundut, L Pop, R Lucacel-Ciceo, G Stiufiuc, R F Badila, I Lupan, O R Koblicska, A Onaciu, D Cenariu and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M BoscaFaculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, Cluj-Napoca, 400641, Romania.
L C BolundutFaculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, Cluj-Napoca, 400641, Romania.
L PopFaculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, Cluj-Napoca, 400641, Romania.
R Lucacel-CiceoFaculty of Physics, Babes-Bolyai University, Cluj-Napoca, 400084, Romania. raluca.lucacel@ubbcluj.ro.
G StiufiucFaculty of Physics, Babes-Bolyai University, Cluj-Napoca, 400084, Romania.
R F BadilaFaculty of Physics, Babes-Bolyai University, Cluj-Napoca, 400084, Romania.
I LupanInstitute for Interdisciplinary Research in Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, 400271, Romania.
O R KoblicskaInstitute for Interdisciplinary Research in Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, 400271, Romania.
A OnaciuInstitute of Medical Research and Life Sciences - MEDFUTURE, Cluj-Napoca, 400349, Romania.
D CenariuInstitute of Medical Research and Life Sciences - MEDFUTURE, Cluj-Napoca, 400349, Romania.
A-B ȚiguInstitute of Medical Research and Life Sciences - MEDFUTURE, Cluj-Napoca, 400349, Romania.
G KatonaFaculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, 400028, Romania.
D SimedruSubsidiary Research Institute for Analytical Instrumentation, INCDO-INOE 2000, Cluj-Napoca, 400293, Romania.
P PascutaFaculty of Materials and Environmental Engineering, Technical University of Cluj-Napoca, Cluj-Napoca, 400641, Romania. Petru.Pascuta@phys.utcluj.ro.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A new vitreous system, 44P

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsPhosphatesRubidiumSilverCell Line, TumorCell ProliferationCell SurvivalFibroblastsGlassHumansMetal NanoparticlesMicrobial Sensitivity TestsX-Ray DiffractionAnti-Bacterial AgentsAntineoplastic AgentsPhosphatesRubidiumSilverAg2OAntibacterial activityCell viabilityPhosphate glassesRb2O

Identifiers

PMID41131063
PMCPMC12549981

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.